Clinical distribution and drug resistance of Stenotrophomonas maltophilia in ICU from 2007 to 2010

HE Qun,ZHENG Ye-ping,WU Jian-xiang,CAI Ji-ming,XU Shao-yi,WU Xiao-yan
2013-01-01
Abstract:OBJECTIVE To study the clinical distribution and drug resistance of Stenotrophomonas maltophilia in the ICU from 2007 to 2010 so as to provide the theoretical basis for rational use of antimicrobial agents.METHODS Retrospective analyses were performed on the results of drug susceptibility testing for 533 strains of S.maltophilia during the past four years.Antimicrobial susceptibility testing was performed by using Kirb-Bauer method.RESULTS The detection rate as well as the resistance rate of S.maltophilia to 15 antibiotics kept an upward trend in the 4 years.The sputum specimens was dominant in the specimens sources,accounting for more than 70.00%,the detection rate increased from 3.69% in 2007 to 4.14% in 2010.The strains were most susceptible to piperacillin/tazobactam with the drug resistance less than 15.00% and were highly sensitive to cefoperazone/sulbactam and levofloxacin,the drug resistance rate to cefepime was increased significantly,increasing from 11.20% in 2008 to 46.10% in 2010.CONCLUSION S.maltophilia is one of the common species of pathogens causing opportunistic nosocomial infections,the detection rate as well as the resistance rate keeps an upward tendency,therefore,it is crucial to reasonably use antibiotics and strengthen the prevention measures so as to effectively prevent the increasing drug resistance rate and the emergence of the multidrug-resistant strains.
What problem does this paper attempt to address?